NovaBridge Biosciences Debt-to-Assets Ratio Growth & History (NBP)

NovaBridge Biosciences's debt-to-assets ratio was 0.01 for fiscal 2025.

View full NovaBridge Biosciences company overview

NovaBridge Biosciences annual debt-to-assets ratio history

NovaBridge Biosciences annual debt-to-assets ratio

Fiscal yearPeriod endedDebt-to-assets ratioChangeGrowth
20252025-12-310.01−0.01−35.50%
20242024-12-310.02−0.01−36.22%
20232023-12-310.030.01+55.47%
20222022-12-310.02−0.00−8.32%
20212021-12-310.020.02+835.18%
20202020-12-310.00−0.03−94.20%
20192019-12-310.04

NovaBridge Biosciences debt-to-assets ratio trends

Over the last five fiscal years, NovaBridge Biosciences's debt-to-assets ratio increased from 0.00 to 0.01, a change of 0.01. The latest reported quarter, Q2 2026, shows 0.02.

About the metric

What the debt-to-assets ratio means

The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.

Calculation and source

How debt-to-assets is calculated

TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review NovaBridge Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about NBP yet. Start the conversation.

Write the first post